Literature DB >> 22349474

[Septic shock and septic cardiomyopathy].

H Ebelt1, K Werdan.   

Abstract

Patients suffering from septic shock often present with not only severe reduction of afterload induced by vasodilation but are also affected by sepsis-induced cardiac dysfunction. Elevated troponin levels, which are typically not caused by coronary ischemia, may indicate septic cardiomyopathy which is characterized both by altered systolic function as well as by disturbances in the regulation of heart rate and heart rate variability. The latter findings are based not only on the dysfunction of the autonomous nervous system but are also the result of the direct interaction of endotoxins with cardiac pacemaker cells. In order to quantify the extent of septic cardiomyopathy, cardiac output has to be considered in the light of the existing afterload, i.e., by the parameter 'afterload-related cardiac performance' (ACP). Therapy of septic shock (and thereby septic cardiomyopathy) is based on the well-known causative, supportive, and adjunctive strategies. Stabilization of cardiac function is assured by volume resuscitation (including blood transfusion) and inotropic support (dobutamine). Further specific therapeutic approaches have not yet been established.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349474     DOI: 10.1007/s00063-011-0031-8

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  26 in total

1.  Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications.

Authors:  Karl Werdan; Anja Oelke; Stefan Hettwer; Sebastian Nuding; Sebastian Bubel; Robert Hoke; Martin Russ; Christine Lautenschläger; Ursula Mueller-Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

2.  Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups.

Authors:  Hendrik Schmidt; Ursula Müller-Werdan; Thomas Hoffmann; Darrel P Francis; Massimo F Piepoli; Mathias Rauchhaus; Roland Prondzinsky; Harald Loppnow; Michael Buerke; Dirk Hoyer; Karl Werdan
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

3.  Early changes in organ function predict eventual survival in severe sepsis.

Authors:  Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

4.  Differential reduction of HCN channel activity by various types of lipopolysaccharide.

Authors:  Udo Klöckner; Uwe Rueckschloss; Claudia Grossmann; Henning Ebelt; Ursula Müller-Werdan; Harald Loppnow; Karl Werdan; Michael Gekle
Journal:  J Mol Cell Cardiol       Date:  2011-05-14       Impact factor: 5.000

5.  Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial.

Authors:  P J Godin; L A Fleisher; A Eidsath; R W Vandivier; H L Preas; S M Banks; T G Buchman; A F Suffredini
Journal:  Crit Care Med       Date:  1996-07       Impact factor: 7.598

6.  Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.

Authors:  Martina Brueckmann; Guenter Huhle; Siegfried Lang; Karl K Haase; Thomas Bertsch; Christel Weiss; Jens J Kaden; Christian Putensen; Martin Borggrefe; Ursula Hoffmann
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

Review 7.  [Septic circulatory shock and septic cardiomyopathy].

Authors:  K Werdan; S Hettwer; S Bubel; A Oelke; R S Hoke; R Wimmer; H Ebelt; U Müller-Werdan
Journal:  Internist (Berl)       Date:  2009-07       Impact factor: 0.743

8.  Association between mitochondrial dysfunction and severity and outcome of septic shock.

Authors:  David Brealey; Michael Brand; Iain Hargreaves; Simon Heales; John Land; Ryszard Smolenski; Nathan A Davies; Chris E Cooper; Mervyn Singer
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

9.  Septic cardiomyopathy - A not yet discovered cardiomyopathy?

Authors:  Ursula Muller-Werdan; Michael Buerke; Henning Ebelt; Konstantin M Heinroth; Anja Herklotz; Harald Loppnow; Martin Ruß; Frithjof Schlegel; Axel Schlitt; Hendrik B Schmidt; Gerold Söffker; Karl Werdan
Journal:  Exp Clin Cardiol       Date:  2006

10.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.

Authors:  C Natanson; P W Eichenholz; R L Danner; P Q Eichacker; W D Hoffman; G C Kuo; S M Banks; T J MacVittie; J E Parrillo
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.